Drug · DIN 02416867
ACH-GABAPENTIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 18, 2025; first marketed June 4, 2014.
- Drug Identification Number (DIN)
- 02416867
- Company (DIN owner)
- Accord Healthcare IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Gabapentin N02BF01
- Class
- Human
- Record last updated
- December 1, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GABAPENTIN | 400 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 18, 2025: NOC 36396Supplement to an Abbreviated New Drug Submission (SANDS) · Administrative: Change in product name. Update to Product Monograph (to align with CRP approved PM)
- March 25, 2014: NOC 15442Supplement to an Abbreviated New Drug Submission (SANDS) · New dosage form
Other DINs named ACH-GABAPENTIN
- DIN 02392526 · Marketed
- DIN 02416840 · Marketed
- DIN 02416859 · Marketed
- DIN 02392534 · Dormant